Prognostic biomarkers to identify patients destined to develop severe Crohn’s disease who may benefit from early biological therapy: protocol for a systematic review, meta-analysis and external validation

Journal article

Open access

Peer reviewed

Steve Halligan, Darren Boone, Gauraang Bhatnagar, Tariq Ahmad, Stuart Bloom, Manuel Rodriguez-Justo, Stuart A. Taylor and Susan Mallett

Systematic reviews, Vol.5(1), pp.206-206

01/12/2016

PMCID: PMC5131410

PMID: 27903285

Abstract

Biological markers

Biomarkers

Crohn’s disease

Diagnostic accuracy

Meta-analysis

Prediction

Prognosis

Protocol

Review, systematic

url

https://doi.org/10.1186/s13643-016-0383-5View

Published (Version of record) Open

1 Record Views

Title: Prognostic biomarkers to identify patients destined to develop severe Crohn’s disease who may benefit from early biological therapy: protocol for a systematic review, meta-analysis and external validation
Creators - without role: Steve Halligan - Centre for Medical Imaging, UCL, London, UK
Darren Boone - Colchester Hospital
Gauraang Bhatnagar - Centre for Medical Imaging, UCL, London, UK
Tariq Ahmad - Royal Devon & Exeter NHS Foundation Trust
Stuart Bloom - University College Hospital
Manuel Rodriguez-Justo - University College Hospital
Stuart A. Taylor - Centre for Medical Imaging, UCL, London, UK
Susan Mallett - University of Birmingham
Publication Details: Systematic reviews, Vol.5(1), pp.206-206
Publisher: BioMed Central
Grant note: 14/210/07 / ;
Identifiers: 9926487908331
Academic Unit: Prince Sattam Bin Abdulaziz University
Language: English
Resource Type: Journal article